Identification of the Immunological Mechanisms that Regulate SARS-CoV-2 Vaccine Durability

调节 SARS-CoV-2 疫苗耐久性的免疫学机制的鉴定

• 批准号: 467067
• 负责人: Hewins Benjamin G
• 金额: $ 1.27万
• 依托单位: Dalhousie University (Nova Scotia)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-12-01 至 2022-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=467067&lang=en
• 关键词: Biomarkers; Breakthrough Cases; Covid-19; Elisa; Humoral Immunity; Rapid Test; Rnaseq; Sars-Cov-2; Vaccine Durability; Vaccine Waning

The COVID-19 pandemic has resulted in over 250 million cases and over five million deaths worldwide. To combat the global crisis, large-scale vaccination efforts have expedited and redefined the timeline for vaccine rollout. Despite the initially high rat

COVID-19大流行已导致全球超过2.5亿例病例和超过500万例死亡。为应对全球危机，大规模疫苗接种工作加快并重新确定了疫苗推广的时间轴。尽管最初的高利率